Berry Genomics Co Ltd (000710) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Berry Genomics Co Ltd (000710) has a cash flow conversion efficiency ratio of -0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-2.18 Million ≈ $-319.41K USD) by net assets (CN¥1.65 Billion ≈ $241.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Berry Genomics Co Ltd worth for the company's overall valuation and market capitalisation.
Berry Genomics Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Berry Genomics Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Berry Genomics Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Berry Genomics Co Ltd ranked by their cash flow conversion efficiency. Explore Berry Genomics Co Ltd (000710) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dolphin Drilling AS
OL:DDRIL
|
-0.040x |
|
Changzhou Langbo Seal Polytron Technologies Co Ltd Class A
SHG:603655
|
0.016x |
|
SPAR Group Ltd
JSE:SPP
|
0.553x |
|
Suzhou Sonavox Electronics Co. Ltd. A
SHG:688533
|
0.090x |
|
Cedar Development Co Ltd
SHE:002485
|
-0.052x |
|
Abaxx Technologies Inc
NEO:ABXX
|
-0.245x |
|
VersaBank
NASDAQ:VBNK
|
-0.112x |
|
BlackRock Limited Duration Income Trust
NYSE:BLW
|
0.038x |
Annual Cash Flow Conversion Efficiency for Berry Genomics Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Berry Genomics Co Ltd from 1998 to 2024. View current stock price of Berry Genomics Co Ltd for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.72 Billion ≈ $250.98 Million |
CN¥87.97 Million ≈ $12.87 Million |
0.051x | -12.46% |
| 2023-12-31 | CN¥1.89 Billion ≈ $277.24 Million |
CN¥111.01 Million ≈ $16.24 Million |
0.059x | +544.41% |
| 2022-12-31 | CN¥2.33 Billion ≈ $340.85 Million |
CN¥21.18 Million ≈ $3.10 Million |
0.009x | -75.60% |
| 2021-12-31 | CN¥2.52 Billion ≈ $369.30 Million |
CN¥94.03 Million ≈ $13.76 Million |
0.037x | -44.05% |
| 2020-12-31 | CN¥2.42 Billion ≈ $354.48 Million |
CN¥161.31 Million ≈ $23.60 Million |
0.067x | +27.01% |
| 2019-12-31 | CN¥2.35 Billion ≈ $343.45 Million |
CN¥123.06 Million ≈ $18.01 Million |
0.052x | -38.40% |
| 2018-12-31 | CN¥1.94 Billion ≈ $284.22 Million |
CN¥165.33 Million ≈ $24.19 Million |
0.085x | +78.65% |
| 2017-12-31 | CN¥1.56 Billion ≈ $228.34 Million |
CN¥74.35 Million ≈ $10.88 Million |
0.048x | +138.30% |
| 2016-12-31 | CN¥114.08 Million ≈ $16.69 Million |
CN¥-14.19 Million ≈ $-2.08 Million |
-0.124x | +79.32% |
| 2015-12-31 | CN¥117.69 Million ≈ $17.22 Million |
CN¥-70.81 Million ≈ $-10.36 Million |
-0.602x | -513.72% |
| 2014-12-31 | CN¥130.03 Million ≈ $19.03 Million |
CN¥18.91 Million ≈ $2.77 Million |
0.145x | +12.60% |
| 2013-12-31 | CN¥121.00 Million ≈ $17.71 Million |
CN¥15.63 Million ≈ $2.29 Million |
0.129x | -66.90% |
| 2012-12-31 | CN¥123.68 Million ≈ $18.10 Million |
CN¥48.27 Million ≈ $7.06 Million |
0.390x | +322.78% |
| 2011-12-31 | CN¥122.50 Million ≈ $17.93 Million |
CN¥-21.46 Million ≈ $-3.14 Million |
-0.175x | -128.10% |
| 2010-12-31 | CN¥122.22 Million ≈ $17.89 Million |
CN¥76.19 Million ≈ $11.15 Million |
0.623x | +3165.21% |
| 2009-12-31 | CN¥114.51 Million ≈ $16.76 Million |
CN¥-2.33 Million ≈ $-340.79K |
-0.020x | -103.67% |
| 2008-12-31 | CN¥104.34 Million ≈ $15.27 Million |
CN¥57.76 Million ≈ $8.45 Million |
0.554x | +1012.22% |
| 2007-12-31 | CN¥94.51 Million ≈ $13.83 Million |
CN¥4.70 Million ≈ $688.23K |
0.050x | -57.48% |
| 2006-12-31 | CN¥99.78 Million ≈ $14.60 Million |
CN¥11.68 Million ≈ $1.71 Million |
0.117x | +52.21% |
| 2005-12-31 | CN¥98.59 Million ≈ $14.43 Million |
CN¥7.58 Million ≈ $1.11 Million |
0.077x | +234.93% |
| 2004-12-31 | CN¥112.75 Million ≈ $16.50 Million |
CN¥-6.43 Million ≈ $-940.18K |
-0.057x | -420.11% |
| 2003-12-31 | CN¥112.11 Million ≈ $16.41 Million |
CN¥-1.23 Million ≈ $-179.74K |
-0.011x | -108.00% |
| 2002-12-31 | CN¥108.87 Million ≈ $15.93 Million |
CN¥14.91 Million ≈ $2.18 Million |
0.137x | +125.90% |
| 2001-12-31 | CN¥161.48 Million ≈ $23.63 Million |
CN¥-85.39 Million ≈ $-12.50 Million |
-0.529x | -1232.97% |
| 2000-12-31 | CN¥207.06 Million ≈ $30.30 Million |
CN¥-8.21 Million ≈ $-1.20 Million |
-0.040x | -157.27% |
| 1999-12-31 | CN¥220.90 Million ≈ $32.33 Million |
CN¥15.30 Million ≈ $2.24 Million |
0.069x | -48.25% |
| 1998-12-31 | CN¥211.44 Million ≈ $30.94 Million |
CN¥28.30 Million ≈ $4.14 Million |
0.134x | -- |
About Berry Genomics Co Ltd
Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcri… Read more